For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
How does the forecasted CAGR of the artificial organs and bionic implants industry compare to other sectors?
The artificial organs and bionic implants market size has grown strongly in recent years. It will grow from $45.02 billion in 2024 to $48.75 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to an increase in the elderly population, a rising incidence of organ failure, advances in minimally invasive and robotic surgery, a rise in demand for electronic bionic implants, and increased healthcare expenditure.
The artificial organs and bionic implants market size is expected to see strong growth in the next few years. It will grow to $66.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing incidences of conditions such as diabetes, cardiovascular diseases, and kidney failure; the prevalence of organ transplants; the rising number of individuals awaiting donors; several advantages of the product to surge; and the increasing number of transplants. Major trends in the forecast period include advancements in 3D bioprinting technology, the integration of nanotechnology, the development of smart implants, utilizing AI to design and optimize artificial organs, and the development of new biocompatible materials.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20487&type=smp
What market trends are acting as primary growth drivers for the artificial organs and bionic implants sector?
The increasing prevalence of organ transplants is expected to propel the growth of the artificial organs and bionic implants market going forward. Organ transplants refer to the surgical procedure in which a healthy organ from a donor is implanted into a recipient whose own organ is diseased, damaged, or non-functional. The increase in organ transplants is driven by rising incidences of chronic diseases and organ failures, along with advancements in medical technology and surgical techniques. Artificial organs and bionic implants aid organ transplantation by providing temporary solutions, reducing wait times, improving patient outcomes, and offering alternatives when donor organs are unavailable. For instance, in January 2023, according to the United Network for Organ Sharing, a US-based non-profit scientific and educational organization, 42,887 organ transplants were performed in the United States in 2022, marking a 3.7% increase over 2021. Therefore, the increasing prevalence of organ transplants is driving the growth of the artificial organs and bionic implants market.
What are the fastest-growing segments in the artificial organs and bionic implants market forecast period?
The artificial organs and bionic implants market covered in this report is segmented –
1) By Product: Artificial Organs, Artificial Bionics
2) By Technology: Mechanical Bionics, Electronic Bionics
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Artificial Organs: Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs
2) By Artificial Bionics: Bionic Limbs, Bionic Eyes, Bionic Ears, Neural Implants, Bionic Skin
View The Full Market Report:
How are emerging trends transforming the artificial organs and bionic implants market dynamics?
Major companies operating in the artificial organs and bionic implants market are focusing on developing technologically advanced solutions, such as brain implant technology systems, to enhance cognitive function and treat neurological disorders. Brain implant technology systems involve devices that interface with the brain to monitor, stimulate, or modify neural activity for medical treatment, neuroprosthetics, or research purposes. For instance, in May 2023, Neuralink Corp., a US-based neurotechnology company, received Food and Drug Administration (FDA) approval to conduct its first human clinical trials for its brain implant technology, which aims to help individuals with severe paralysis regain the ability to communicate with and control external devices using only their thoughts. The approval marks a significant milestone for the company, which has faced challenges in the past, including a previous rejection due to safety concerns. The trial will test the device’s ability to interpret neural signals and transmit them via Bluetooth to control computers and mobile devices, potentially assisting those with conditions such as amyotrophic lateral sclerosis (ALS).
Which major players hold significant market share in the artificial organs and bionic implants sector?
Major companies operating in the artificial organs and bionic implants market are Medtronic plc, Asahi Kasei Medical Co. Ltd., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Terumo Medical Corp., Edwards Lifesciences Corporation, Ottobock SE and Co. KGaA, Cochlear Limited, Ossur hf., Thoratec Corporation, Berlin Heart GmbH, Jarvik Heart Inc., SynCardia Systems LLC, BiVACOR Inc., Gambro AB, Pixium Vision, ALVI Labs, WillowWood Global LLC, Nano Retina Inc., Organovo Holdings Inc.
Which regional segments are forecasted to witness the fastest growth in the artificial organs and bionic implants market?
North America was the largest region in the artificial organs and bionic implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organs and bionic implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Artificial Organs And Bionic Implants Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20487
Need Customized Data On Artificial Organs And Bionic Implants Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20487&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
